{"gene":"GALR1","run_date":"2026-04-28T18:06:52","timeline":{"discoveries":[{"year":1998,"finding":"GalR1 couples to Gi protein to inhibit adenylyl cyclase (cAMP production), and activates MAPK through a Gi-betagamma signaling pathway (sensitive to beta-ARKct inhibition but not PKC inhibition), while failing to couple to Gs or Gq/G11.","method":"CHO cell transfection, cAMP assay, pertussis toxin treatment, beta-ARKct expression, PKC inhibitor treatment, MAPK assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal pharmacological and signaling assays in recombinant system, replicated across GalR1 vs GalR2 comparisons","pmids":["9578554"],"is_preprint":false},{"year":1995,"finding":"Rat GALR1 is a G protein-coupled receptor that binds galanin with high affinity and inhibits basal and forskolin-stimulated cAMP formation via a pertussis toxin-sensitive G protein in CHO cells.","method":"cDNA cloning, radioligand binding in COS1 cells, cAMP assay with pertussis toxin in CHO cells","journal":"Brain research. Molecular brain research","confidence":"High","confidence_rationale":"Tier 1 — reconstituted receptor in heterologous cells with functional cAMP assay and pertussis toxin validation","pmids":["8750821"],"is_preprint":false},{"year":1997,"finding":"Site-directed mutagenesis of GalR1 identified His264 and Phe282 as directly involved in galanin binding (mutation reduces binding 20-fold but retains partial cAMP signaling), Glu271 interacts with the N-terminus of galanin, and Phe115 in TM III is structurally important for the ligand binding pocket.","method":"Site-directed mutagenesis, radioligand binding, adenylyl cyclase inhibition assay","journal":"European journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with mutagenesis and functional assay, multiple residues characterized","pmids":["9370372"],"is_preprint":false},{"year":1998,"finding":"The N-terminal portion of galanin binds to a hydrophobic pocket within GalR1, and ligand binding is followed by rapid GalR1-mediated internalization of the agonist-receptor complex via an energy-requiring endocytic process (t1/2 ~10 min, ~78% internalization, blocked by sucrose).","method":"Fluorescein-galanin (F-Gal) probe, fluorescence quenching by KI, flow cytometry in transfected CHO cells, temperature and sucrose inhibition controls","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1-2 — direct biophysical measurement of ligand-receptor interaction and receptor internalization with multiple controls","pmids":["9649336"],"is_preprint":false},{"year":2002,"finding":"Molecular modelling and mutagenesis of hGALR1 identified Phe186 in the second extracellular loop as making hydrophobic contact with galanin (Ala7/Leu11); Glu271 interacts with the N-terminus of galanin; Phe115 is structurally important to the binding pocket; and Phe282 interacts with Trp2 of galanin via an aromatic-aromatic interaction.","method":"Molecular modelling based on frog rhodopsin alpha-carbon maps, site-directed mutagenesis, radioligand binding with subtype-selective ligands","journal":"Protein engineering","confidence":"High","confidence_rationale":"Tier 1 — structure-guided mutagenesis with functional binding validation for multiple residues","pmids":["11983932"],"is_preprint":false},{"year":1998,"finding":"Human GALR1 expressed in HEK293E cells shows two affinity states (picomolar and nanomolar), inhibits forskolin-stimulated cAMP, and stimulates GTPgammaS binding; chimeric galanin peptides including M40 act as full agonists at GALR1 in vitro despite antagonist effects in vivo.","method":"Stable episomal expression in HEK293E cells, saturation binding isotherms, SPA assay, cAMP inhibition assay, GTPgammaS binding, receptor inactivation by partial alkylation","journal":"The Journal of pharmacology and experimental therapeutics","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal assays including receptor reserve experiments with rigorous controls","pmids":["9808667"],"is_preprint":false},{"year":2008,"finding":"GalR1 activation by the selective agonist M617 inhibits N- and P/Q-type voltage-dependent calcium channels via Galphai-protein betagamma subunits in rat nucleus tractus solitarius neurons.","method":"Patch-clamp whole-cell recording, selective GalR1 agonist M617, depolarizing prepulse protocol, intracellular dialysis of Galphai antibody, M35 antagonist","journal":"Brain research","confidence":"High","confidence_rationale":"Tier 1-2 — electrophysiology with selective agonist/antagonist pharmacology and intracellular antibody blockade of signaling component","pmids":["18602374"],"is_preprint":false},{"year":2003,"finding":"GalR1 mediates direct postsynaptic inhibitory actions of galanin on arcuate nucleus neurons by activating an inwardly-rectifying K+ conductance (reversal potential ~-94 mV), confirmed by co-expression of Gal-R1 mRNA in responsive neurons and blockade by galantide.","method":"Sharp microelectrode current-clamp recordings in brain slices, biocytin filling, in situ hybridization for Gal-R1 mRNA, TTX treatment, galantide antagonism","journal":"Neuroendocrinology","confidence":"High","confidence_rationale":"Tier 1-2 — electrophysiology with pharmacological validation, TTX control, and post-hoc mRNA confirmation in recorded neurons","pmids":["12915763"],"is_preprint":false},{"year":2007,"finding":"GalR1 activation in substantia gelatinosa neurons activates an inwardly-rectifying conductance and has little effect on presynaptic spontaneous EPSCs, while GalR2 activation decreases membrane excitability and acts presynaptically to reduce EPSC frequency; consistent with GalR1 coupling to Gi/o.","method":"Whole-cell patch-clamp recording in rat spinal cord slices, selective GalR1 agonist cocktail (AR-M961 + M871), selective GalR2 agonist AR-M1896","journal":"Pain","confidence":"High","confidence_rationale":"Tier 1-2 — electrophysiology with selective receptor pharmacology distinguishing GalR1 vs GalR2 mechanisms","pmids":["17910903"],"is_preprint":false},{"year":2014,"finding":"GalR1 and its ligand galanin promote chemoresistance in colorectal cancer; silencing GalR1 induces caspase-8-dependent apoptosis by downregulating the caspase-8 inhibitor FLIPL.","method":"RNAi functional screening, siRNA knockdown, apoptosis assays, Western blot for caspase-8 and FLIPL","journal":"Clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — RNAi knockdown with defined molecular pathway (FLIPL/caspase-8), single lab","pmids":["22859720"],"is_preprint":false},{"year":2005,"finding":"GalR1 protein levels in the locus coeruleus are regulated by cAMP-dependent mechanisms: GalR1 (but not GalR2 or GalR3) is upregulated in LC-like Cath.a cells by cAMP elevation and is increased in galanin knockout mice where loss of galanin-maintained cAMP tone leads to increased CREB phosphorylation and elevated GalR1 expression.","method":"Western blot, mRNA quantification in cell lines and knockout mice, cAMP manipulation, CREB phosphorylation analysis","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — genetic knockout plus pharmacological cAMP manipulation, single lab","pmids":["15934937"],"is_preprint":false},{"year":2002,"finding":"GALR1 knockout mice exhibit spontaneous tonic-clonic seizures and reduced circulating IGF-I levels, demonstrating that GALR1 is required for galanin's anti-seizure activity and for neuroendocrine regulation.","method":"Insertional gene knockout, seizure monitoring, IGF-I radioimmunoassay","journal":"Brain research. Molecular brain research","confidence":"High","confidence_rationale":"Tier 2 — clean knockout with defined seizure and neuroendocrine phenotype, replicated in second knockout line","pmids":["12487125"],"is_preprint":false},{"year":2004,"finding":"GalR1 mediates galanin's protection from seizures and hippocampal injury in Li-pilocarpine and perforant path stimulation models of status epilepticus but not in kainic acid-induced seizures, as shown by more severe seizures and greater CA1 and hilar cell injury in GalR1 knockout mice.","method":"GalR1 knockout mice, Li-pilocarpine, electrical PPS, and kainic acid SE models, FluoroJade B, TUNEL staining, BrdU neurogenesis labeling","journal":"Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — clean knockout with three independent models and multiple readouts, model-specific dissection of GalR1 role","pmids":["15350653"],"is_preprint":false},{"year":2001,"finding":"Low-dose galanin-induced spinal pronociception is mediated by GalR2 receptors, while high-dose galanin antiallodynic effects in neuropathic pain are mediated by GalR1 receptors, established by comparing equimolar doses of the GalR2-selective agonist AR-M1896 and the GalR1/2 agonist AR-M961 in rat spinal cord.","method":"Intrathecal infusion/injection, selective GalR2 agonist AR-M1896, GalR1/2 agonist AR-M961, Bennett neuropathic pain model, von Frey and cold allodynia testing","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — selective agonist pharmacology with dose-response in vivo, receptor subtype dissection","pmids":["11481429"],"is_preprint":false},{"year":2003,"finding":"Spinal antinociception by intrathecal galanin is mediated by GalR1 receptors, and galanin synergizes with morphine and the NMDA antagonist AP-5 at the spinal level, as shown by isobolographic analysis.","method":"Intrathecal injection, formalin test with automated flinch detection, isobolographic analysis, comparison of GalR1/2 agonist vs GalR2-selective agonist potencies","journal":"The Journal of pharmacology and experimental therapeutics","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological in vivo study with isobolographic analysis, receptor subtype inferred from agonist pharmacology","pmids":["14610237"],"is_preprint":false},{"year":2014,"finding":"GalR1 and GalR2 form heteroreceptor complexes (GalR1-GalR2 heteromers) in HEK293T cells, demonstrated by proximity ligation assay and BRET2; within the complex, the GalR1 protomer has increased affinity for galanin(1-15) vs galanin(1-29), preferentially inhibiting CREB via Gi, while GalR2 mediates Gq/11-dependent NFAT signaling.","method":"Proximity ligation assay, BRET2, CRE luciferase reporter assay, NFAT reporter assay, selective antagonists (M35, M871)","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — heteromer detection with two orthogonal methods plus functional signaling readouts, single lab","pmids":["25152404"],"is_preprint":false},{"year":2015,"finding":"GalR1 forms heteroreceptor complexes with 5-HT1A and GPR39, demonstrated by FRET and co-immunopurification; the GalR1-5-HT1A-GPR39 heterocomplex shows different signaling compared to individual homo/monomeric receptors, and this complex formation is modulated by zinc.","method":"FRET, co-immunopurification, functional signaling assays, zinc treatment","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2-3 — heteromer detection with two methods, functional differences shown, single lab","pmids":["26365466"],"is_preprint":false},{"year":2017,"finding":"GalR1 mediates galanin's neuroprotection against ischemic injury by inhibiting caspase-8 and caspase-12-initiated apoptosis (but not caspase-9), potentially via cPKCgamma signaling; GalR2/3 agonist did not replicate the effect and lentiviral GalR1 knockdown abolished galanin-induced neuroprotection.","method":"MCAO/reperfusion mouse model, OGD in primary neurons, lentiviral RNAi knockdown of GalR1, GalR2/3 agonist AR-M1896, caspase activity assays, cPKCgamma knockout neurons","journal":"Aging and disease","confidence":"Medium","confidence_rationale":"Tier 2 — receptor-selective knockdown and knockout neurons with defined apoptotic pathway, single lab","pmids":["28203483"],"is_preprint":false},{"year":2021,"finding":"The transcription factor Scratch2 binds to an E-box element in the GalR1 promoter region (-250 to -220) to repress GalR1 gene expression; decreased Scratch2 in the ventral PAG of chronically stressed rats leads to elevated GalR1 expression and depression-like behavior.","method":"Promoter reporter assays, Scratch2 binding to E-box (in vitro molecular biology), Scratch2 knockdown in rat vPAG, behavioral testing, RNAscope in situ hybridization","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — promoter functional assay combined with in vivo knockdown and behavioral validation, single lab","pmids":["34108238"],"is_preprint":false},{"year":1997,"finding":"GALR1 mRNA is co-expressed in extrahypothalamic vasopressin/galanin neurons (~95% co-expression) but is absent from cholinergic neurons in the medial septum/diagonal band, suggesting galanin modulates basal forebrain cholinergic activity indirectly rather than via direct GalR1 action on cholinergic neurons.","method":"Double in situ hybridization histochemistry with GALR1 and choline acetyltransferase or vasopressin/galanin riboprobes","journal":"Brain research. Molecular brain research","confidence":"Medium","confidence_rationale":"Tier 2 — dual-label in situ hybridization with clear cellular resolution, single lab","pmids":["9450684"],"is_preprint":false},{"year":1997,"finding":"Mouse GalR1 coding sequence is uniquely divided into three exons: exon 1 encodes N-terminal region through TM5, exon 2 encodes the third intracellular loop, and exon 3 encodes TM6 through the C-terminus; the receptor functionally inhibits cAMP when expressed from cDNA.","method":"Genomic cloning, cDNA cloning, functional cAMP assay in transfected cells","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 1-2 — genomic structure determined with functional validation, single lab","pmids":["9271210"],"is_preprint":false},{"year":2005,"finding":"Under standard autoradiographic binding conditions, [125I]-galanin binding in mouse brain is exclusively attributable to GalR1 (not GalR2 or GalR3), as no specific binding was detected in any brain region of GalR1 knockout mice.","method":"Autoradiographic radioligand binding in GalR1 knockout vs wild-type and galanin knockout mouse brain sections","journal":"Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout confirms receptor identity underlying binding signal, strong evidence","pmids":["15708483"],"is_preprint":false},{"year":2018,"finding":"GALR1 knockdown in the prefrontal cortex of postpartum depression model rats alleviates depressive-like behavior and reverses downregulation of CREB-BDNF signaling and 5-HT levels, implicating GalR1 in PFC in suppressing CREB/BDNF/5-HT pathways.","method":"siRNA knockdown of GALR1 in rat PFC, behavioral tests, Western blot for CREB-BDNF signaling, HPLC for 5-HT measurement","journal":"Frontiers in psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 — region-specific knockdown with molecular pathway and behavioral readouts, single lab","pmids":["30487761"],"is_preprint":false},{"year":2007,"finding":"GAL-R1 and GAL-R2 (but not GAL-R3) are expressed in rat adrenocortical cells and mediate galanin-stimulated corticosterone secretion via the adenylate cyclase/PKA-dependent signaling pathway (not phospholipase C/PKC), as shown by immunoblockade of receptors and pharmacological inhibitors.","method":"RT-PCR, [3H]galanin binding with receptor immunoblockade, cAMP and inositol triphosphate assays, adenylate cyclase and PKA inhibitors, corticosterone RIA","journal":"International journal of molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 — receptor immunoblockade with pharmacological pathway dissection, multiple readouts","pmids":["17143559"],"is_preprint":false},{"year":2024,"finding":"GalR1 is predominantly expressed in glutamatergic neurons in both the ventral PFC and ventral hippocampus; optogenetic excitation of GalR1-expressing neurons in the vPFC (but not vHC) disrupts visuospatial attention; vPFC GalR1 neurons increase activity during correct attentive actions while vHC GalR1 neurons increase activity during impulsive errors.","method":"Multiplex fluorescent in situ hybridization, novel viral approach for GalR1-expressing neuron targeting, optogenetics, fiber photometry, 5-choice serial reaction time task","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — optogenetics and photometry with circuit-specific functional dissection, preprint","pmids":["bio_10.1101_2024.07.29.605653"],"is_preprint":true}],"current_model":"GALR1 is a Gi-coupled GPCR that inhibits adenylyl cyclase, activates MAPK via Gi-betagamma subunits, and inhibits N- and P/Q-type calcium channels; ligand binding involves a hydrophobic pocket with key residues His264, Phe282, Glu271, and Phe115, followed by rapid receptor-mediated internalization; GalR1 can form heteroreceptor complexes with GalR2 (altering galanin fragment selectivity) and with 5-HT1A/GPR39; in vivo, GalR1 mediates galanin's anticonvulsant, antinociceptive, and neuroprotective effects, suppresses pro-apoptotic caspase-8/12 signaling, and modulates cognitive and affective behaviors through glutamatergic neurons in frontotemporal circuits, with its expression regulated by the transcription factor Scratch2 and by cAMP/CREB-dependent mechanisms."},"narrative":{"teleology":[{"year":1995,"claim":"Cloning of rat GALR1 established it as a high-affinity galanin receptor coupled to pertussis-toxin-sensitive Gi protein that inhibits cAMP, resolving the molecular identity of the first galanin receptor subtype.","evidence":"cDNA cloning, radioligand binding in COS1 cells, cAMP assay with pertussis toxin in CHO cells","pmids":["8750821"],"confidence":"High","gaps":["Downstream effectors beyond cAMP not yet characterized","In vivo relevance not tested","Receptor subtype selectivity unknown"]},{"year":1997,"claim":"Site-directed mutagenesis and genomic characterization defined the ligand-binding pocket architecture of GALR1, identifying His264, Phe282, Glu271, and Phe115 as key determinants of galanin recognition and revealing a unique three-exon gene structure.","evidence":"Site-directed mutagenesis with radioligand binding and adenylyl cyclase assays; genomic cloning of mouse GalR1","pmids":["9370372","9271210"],"confidence":"High","gaps":["No crystal or cryo-EM structure available","Contributions of extracellular loop residues not yet mapped"]},{"year":1998,"claim":"Characterization of GALR1 signaling revealed that it activates MAPK through Gβγ subunits (not PKC), displays two-affinity-state binding, and undergoes rapid agonist-induced internalization, establishing the full proximal signaling and trafficking repertoire.","evidence":"CHO and HEK293E cell transfection with βARKct blockade, MAPK assay, fluorescein-galanin internalization by flow cytometry, receptor alkylation studies","pmids":["9578554","9808667","9649336"],"confidence":"High","gaps":["Internalization machinery (arrestin involvement) not identified","Recycling versus degradation fate unknown"]},{"year":2001,"claim":"Selective agonist pharmacology in vivo demonstrated that spinal antinociception at high galanin doses is specifically mediated by GALR1, separating it from GalR2-mediated pronociceptive effects and establishing GALR1 as a therapeutic target for neuropathic pain.","evidence":"Intrathecal GalR1/2 agonist AR-M961 vs GalR2-selective AR-M1896 in rat Bennett neuropathic pain model with allodynia testing","pmids":["11481429"],"confidence":"High","gaps":["Spinal circuit identity of GalR1-expressing neurons unknown","Whether GALR1 is sufficient or only necessary for antiallodynia not resolved"]},{"year":2002,"claim":"GALR1 knockout mice showed spontaneous seizures and reduced IGF-I, proving GALR1 is required for galanin's anticonvulsant function and contributes to neuroendocrine homeostasis — the first genetic loss-of-function evidence for a galanin receptor in vivo.","evidence":"Insertional gene knockout, seizure monitoring, IGF-I radioimmunoassay; further refined by Phe186 mutagenesis of the binding pocket","pmids":["12487125","11983932"],"confidence":"High","gaps":["Seizure mechanism (circuit vs molecular) not dissected","Compensatory changes in GalR2/R3 not assessed"]},{"year":2003,"claim":"Electrophysiology in brain slices revealed that GALR1 mediates postsynaptic inhibition by activating inwardly rectifying K⁺ channels in arcuate nucleus neurons, defining the ionic mechanism underlying GALR1's inhibitory actions on neuronal excitability.","evidence":"Sharp microelectrode recordings in brain slices with galantide antagonism, TTX, and post-hoc in situ hybridization for GalR1 mRNA","pmids":["12915763"],"confidence":"High","gaps":["Specific GIRK channel subunit identity not determined","Whether this mechanism generalizes to all GALR1-expressing neurons unknown"]},{"year":2004,"claim":"Model-specific analysis in GALR1 knockouts demonstrated that GALR1's neuroprotective role extends to hippocampal cell survival during status epilepticus (pilocarpine and perforant path models) but not kainic acid seizures, revealing stimulus-dependent engagement of the receptor.","evidence":"GalR1 knockout mice in three SE models, FluoroJade B and TUNEL staining, BrdU neurogenesis labeling","pmids":["15350653"],"confidence":"High","gaps":["Why kainic acid seizures bypass GALR1 is unexplained","Downstream neuroprotective effectors not identified at this stage"]},{"year":2005,"claim":"GALR1 expression itself is regulated by cAMP/CREB signaling — a feedback loop whereby Gi-mediated cAMP suppression by galanin normally restrains GALR1 levels, while loss of galanin tone increases CREB phosphorylation and upregulates GALR1.","evidence":"Western blot and mRNA quantification in Cath.a cells and galanin knockout mice with cAMP manipulation and CREB phosphorylation analysis","pmids":["15934937"],"confidence":"Medium","gaps":["Whether CREB directly binds the GALR1 promoter not shown","Feedback dynamics under physiological conditions not measured"]},{"year":2007,"claim":"GALR1 was shown to inhibit N- and P/Q-type calcium channels via Gαi-βγ subunits and to act purely postsynaptically in spinal cord, further distinguishing its effector repertoire from GalR2's presynaptic actions.","evidence":"Patch-clamp in NTS neurons with selective agonist M617, Gαi antibody dialysis; whole-cell recordings in spinal substantia gelatinosa slices with receptor-selective agonists","pmids":["18602374","17910903"],"confidence":"High","gaps":["Calcium channel subunit specificity (α1 subunit identity) not determined","Mechanism of voltage-dependent relief not fully resolved"]},{"year":2014,"claim":"Discovery that GALR1 forms heteroreceptor complexes with GalR2 (shifting galanin fragment selectivity and Gi vs Gq coupling bias) and promotes chemoresistance in colorectal cancer by suppressing caspase-8/FLIPL-dependent apoptosis expanded GALR1's roles beyond classical neuromodulation.","evidence":"PLA and BRET2 for heteromer detection with CRE/NFAT reporters; RNAi screening in CRC cells with caspase-8 and FLIPL Western blots","pmids":["25152404","22859720"],"confidence":"Medium","gaps":["GalR1-GalR2 heteromer existence in native neurons not confirmed","FLIPL regulation mechanism (transcriptional vs post-translational) not resolved","Cancer relevance based on cell lines only"]},{"year":2017,"claim":"GALR1 was identified as the specific receptor subtype mediating galanin's neuroprotection against ischemic injury, acting through inhibition of caspase-8 and caspase-12 (but not caspase-9), potentially via cPKCγ signaling.","evidence":"MCAO/reperfusion model, OGD in primary neurons, lentiviral GalR1 knockdown, cPKCγ knockout neurons, caspase activity assays","pmids":["28203483"],"confidence":"Medium","gaps":["cPKCγ link is correlative, not yet confirmed by rescue experiments","Whether caspase-8 inhibition in ischemia and cancer share the same mechanism unknown"]},{"year":2018,"claim":"Region-specific GALR1 knockdown in prefrontal cortex alleviated depression-like behavior and restored CREB-BDNF-5-HT signaling, directly linking cortical GALR1 activity to suppression of monoaminergic and neurotrophic pathways relevant to mood.","evidence":"siRNA knockdown of GALR1 in rat PFC, behavioral tests, Western blot, HPLC for 5-HT","pmids":["30487761"],"confidence":"Medium","gaps":["Cell-type specificity of PFC GALR1 effects not determined","Whether CREB-BDNF suppression is direct or secondary to cAMP inhibition unclear"]},{"year":2021,"claim":"Identification of Scratch2 as a transcriptional repressor of GALR1 via an E-box element in the promoter provided the first defined transcription factor regulating GALR1 expression and linked this regulation to stress-induced depression-like behavior.","evidence":"Promoter reporter assays, Scratch2 knockdown in rat ventral PAG, RNAscope in situ hybridization, behavioral testing","pmids":["34108238"],"confidence":"Medium","gaps":["Direct Scratch2 binding to GALR1 promoter not shown by ChIP","Whether Scratch2 regulation is brain-region specific not addressed"]},{"year":null,"claim":"Key unresolved questions include the structural basis of GALR1 activation (no experimental structure), the identity of arrestin/scaffolding proteins mediating internalization, whether GalR1-GalR2 and GalR1-5HT1A heteromers exist in native brain tissue, and the cell-type-specific circuit mechanisms by which GALR1 controls seizure threshold and affective behavior.","evidence":"","pmids":[],"confidence":"Low","gaps":["No experimental 3D structure of GALR1","Heteromer formation unconfirmed in vivo","Circuit-level mechanism of anticonvulsant action not resolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1,5,6,7,8]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[6,7,8]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,5,15]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,5,6,7,8,15,16]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[6,7,8,12,13]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[9,17]}],"complexes":["GalR1-GalR2 heteromer","GalR1-5-HT1A-GPR39 heterocomplex"],"partners":["GALR2","HTR1A","GPR39","GAL"],"other_free_text":[]},"mechanistic_narrative":"GALR1 is a Gi/o-coupled galanin receptor that functions as an inhibitory modulator of neuronal excitability, nociception, seizure susceptibility, and affective behavior. Upon galanin binding to a hydrophobic pocket involving His264, Phe282, Glu271, Phe115, and Phe186, GALR1 inhibits adenylyl cyclase, activates MAPK via Gβγ subunits, opens inwardly rectifying K⁺ channels, and inhibits N- and P/Q-type voltage-dependent calcium channels, followed by rapid clathrin-dependent receptor internalization [PMID:9578554, PMID:9370372, PMID:9649336, PMID:18602374, PMID:12915763]. GALR1 knockout mice exhibit spontaneous seizures and enhanced hippocampal injury in status epilepticus models, establishing GALR1 as the primary mediator of galanin's anticonvulsant and neuroprotective actions, and high-dose spinal galanin antinociception also operates through GALR1 [PMID:12487125, PMID:15350653, PMID:11481429]. GALR1 forms heteroreceptor complexes with GalR2 and with 5-HT1A/GPR39 that alter ligand selectivity and downstream signaling, and its transcription is repressed by the E-box-binding factor Scratch2 and positively regulated by cAMP/CREB-dependent mechanisms [PMID:25152404, PMID:26365466, PMID:34108238, PMID:15934937]."},"prefetch_data":{"uniprot":{"accession":"P47211","full_name":"Galanin receptor type 1","aliases":[],"length_aa":349,"mass_kda":39.0,"function":"Receptor for the hormone galanin. The activity of this receptor is mediated by G proteins that inhibit adenylate cyclase activity","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P47211/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GALR1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GALR1","total_profiled":1310},"omim":[{"mim_id":"619246","title":"SPEXIN HORMONE; SPX","url":"https://www.omim.org/entry/619246"},{"mim_id":"618487","title":"G PROTEIN-COUPLED RECEPTOR 151; GPR151","url":"https://www.omim.org/entry/618487"},{"mim_id":"616461","title":"EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8","url":"https://www.omim.org/entry/616461"},{"mim_id":"611178","title":"GALANIN-LIKE PEPTIDE; GALP","url":"https://www.omim.org/entry/611178"},{"mim_id":"606925","title":"PYROGLUTAMYLATED RF-AMIDE PEPTIDE RECEPTOR; QRFPR","url":"https://www.omim.org/entry/606925"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"adrenal gland","ntpm":1.4},{"tissue":"pituitary gland","ntpm":1.3}],"url":"https://www.proteinatlas.org/search/GALR1"},"hgnc":{"alias_symbol":[],"prev_symbol":["GALNR1","GALNR"]},"alphafold":{"accession":"P47211","domains":[{"cath_id":"1.20.1070.10","chopping":"32-312","consensus_level":"high","plddt":91.9932,"start":32,"end":312}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P47211","model_url":"https://alphafold.ebi.ac.uk/files/AF-P47211-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P47211-F1-predicted_aligned_error_v6.png","plddt_mean":83.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GALR1","jax_strain_url":"https://www.jax.org/strain/search?query=GALR1"},"sequence":{"accession":"P47211","fasta_url":"https://rest.uniprot.org/uniprotkb/P47211.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P47211/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P47211"}},"corpus_meta":[{"pmid":"10379831","id":"PMC_10379831","title":"Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: distinct distribution from GALR1.","date":"1999","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/10379831","citation_count":282,"is_preprint":false},{"pmid":"9578554","id":"PMC_9578554","title":"Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes.","date":"1998","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9578554","citation_count":212,"is_preprint":false},{"pmid":"8750821","id":"PMC_8750821","title":"Cloning and characterization of the rat GALR1 galanin receptor from Rin14B insulinoma cells.","date":"1995","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/8750821","citation_count":196,"is_preprint":false},{"pmid":"11481429","id":"PMC_11481429","title":"Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: selective actions via GalR1 and GalR2 receptors.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11481429","citation_count":181,"is_preprint":false},{"pmid":"12700679","id":"PMC_12700679","title":"Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze.","date":"2003","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12700679","citation_count":161,"is_preprint":false},{"pmid":"15350653","id":"PMC_15350653","title":"Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice.","date":"2004","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15350653","citation_count":79,"is_preprint":false},{"pmid":"12487125","id":"PMC_12487125","title":"Critical role for GALR1 galanin receptor in galanin regulation of neuroendocrine function and seizure activity.","date":"2002","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/12487125","citation_count":77,"is_preprint":false},{"pmid":"15016096","id":"PMC_15016096","title":"Learning and memory performance in mice lacking the GAL-R1 subtype of galanin receptor.","date":"2004","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15016096","citation_count":66,"is_preprint":false},{"pmid":"9380273","id":"PMC_9380273","title":"Semiquantitative distribution of galanin-receptor (GAL-R1) mRNA-containing cells in the male rat hypothalamus.","date":"1997","source":"Neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9380273","citation_count":65,"is_preprint":false},{"pmid":"9271210","id":"PMC_9271210","title":"Genomic organization and functional characterization of the mouse GalR1 galanin receptor.","date":"1997","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9271210","citation_count":64,"is_preprint":false},{"pmid":"15514977","id":"PMC_15514977","title":"Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain.","date":"2004","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15514977","citation_count":60,"is_preprint":false},{"pmid":"14610237","id":"PMC_14610237","title":"Galanin acts at GalR1 receptors in spinal antinociception: synergy with morphine and AP-5.","date":"2003","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/14610237","citation_count":58,"is_preprint":false},{"pmid":"19159918","id":"PMC_19159918","title":"Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice.","date":"2009","source":"Naunyn-Schmiedeberg's archives of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19159918","citation_count":57,"is_preprint":false},{"pmid":"22859720","id":"PMC_22859720","title":"Identification of galanin and its receptor GalR1 as novel determinants of resistance to chemotherapy and potential biomarkers in colorectal cancer.","date":"2012","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/22859720","citation_count":51,"is_preprint":false},{"pmid":"10520130","id":"PMC_10520130","title":"Evidence for expression of galanin receptor Gal-R1 mRNA in certain gonadotropin releasing hormone neurones of the rostral preoptic area.","date":"1999","source":"Journal of neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10520130","citation_count":49,"is_preprint":false},{"pmid":"12887433","id":"PMC_12887433","title":"Altered hippocampal expression of neuropeptides in seizure-prone GALR1 knockout mice.","date":"2003","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/12887433","citation_count":47,"is_preprint":false},{"pmid":"15944016","id":"PMC_15944016","title":"Galanin impairs performance on learning and memory tasks: findings from galanin transgenic and GAL-R1 knockout mice.","date":"2005","source":"Neuropeptides","url":"https://pubmed.ncbi.nlm.nih.gov/15944016","citation_count":37,"is_preprint":false},{"pmid":"9168941","id":"PMC_9168941","title":"Pharmacological characterization and tissue distribution of the human and rat GALR1 receptors.","date":"1997","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9168941","citation_count":37,"is_preprint":false},{"pmid":"25152404","id":"PMC_25152404","title":"Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25152404","citation_count":36,"is_preprint":false},{"pmid":"10803589","id":"PMC_10803589","title":"Expression of GalR1 and GalR2 galanin receptor messenger ribonucleic acid in proopiomelanocortin neurons of the rat arcuate nucleus: effect of testosterone.","date":"2000","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10803589","citation_count":36,"is_preprint":false},{"pmid":"20121116","id":"PMC_20121116","title":"Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery.","date":"2010","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20121116","citation_count":35,"is_preprint":false},{"pmid":"26365466","id":"PMC_26365466","title":"The zinc binding receptor GPR39 interacts with 5-HT1A and GalR1 to form dynamic heteroreceptor complexes with signaling diversity.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/26365466","citation_count":33,"is_preprint":false},{"pmid":"10882839","id":"PMC_10882839","title":"Upregulation of galanin binding sites and GalR1 mRNA levels in the mouse locus coeruleus following chronic morphine treatments and precipitated morphine withdrawal.","date":"2000","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10882839","citation_count":33,"is_preprint":false},{"pmid":"9649336","id":"PMC_9649336","title":"Evidence for hydrophobic interaction between galanin and the GalR1 galanin receptor and GalR1-mediated ligand internalization: fluorescent probing with a fluorescein-galanin.","date":"1998","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9649336","citation_count":33,"is_preprint":false},{"pmid":"9751492","id":"PMC_9751492","title":"Effects of estrous cyclicity on the expression of the galanin receptor Gal-R1 in the rat preoptic area: a comparison with the male.","date":"1998","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9751492","citation_count":31,"is_preprint":false},{"pmid":"9367674","id":"PMC_9367674","title":"Structural organization of the mouse and human GALR1 galanin receptor genes (Galnr and GALNR) and chromosomal localization of the mouse gene.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9367674","citation_count":30,"is_preprint":false},{"pmid":"15934937","id":"PMC_15934937","title":"GalR1, but not GalR2 or GalR3, levels are regulated by galanin signaling in the locus coeruleus through a cyclic AMP-dependent mechanism.","date":"2005","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15934937","citation_count":29,"is_preprint":false},{"pmid":"17910903","id":"PMC_17910903","title":"Selective stimulation of GalR1 and GalR2 in rat substantia gelatinosa reveals a cellular basis for the anti- and pro-nociceptive actions of galanin.","date":"2007","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/17910903","citation_count":28,"is_preprint":false},{"pmid":"11983932","id":"PMC_11983932","title":"Molecular modelling and site-directed mutagenesis of human GALR1 galanin receptor defines determinants of receptor subtype specificity.","date":"2002","source":"Protein engineering","url":"https://pubmed.ncbi.nlm.nih.gov/11983932","citation_count":28,"is_preprint":false},{"pmid":"9370372","id":"PMC_9370372","title":"Mutagenesis and ligand modification studies on galanin binding to its GTP-binding-protein-coupled receptor GalR1.","date":"1997","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9370372","citation_count":27,"is_preprint":false},{"pmid":"21796100","id":"PMC_21796100","title":"The neuropeptide galanin and variants in the GalR1 gene are associated with nicotine dependence.","date":"2011","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21796100","citation_count":26,"is_preprint":false},{"pmid":"15708483","id":"PMC_15708483","title":"[125I]-Galanin binding in brain of wildtype, and galanin- and GalR1-knockout mice: strain and species differences in GalR1 density and distribution.","date":"2005","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15708483","citation_count":26,"is_preprint":false},{"pmid":"9450684","id":"PMC_9450684","title":"GALR1 galanin receptor mRNA is co-expressed by galanin neurons but not cholinergic neurons in the rat basal forebrain.","date":"1997","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9450684","citation_count":25,"is_preprint":false},{"pmid":"22373943","id":"PMC_22373943","title":"Pharmacogenetic association of the galanin receptor (GALR1) SNP rs2717162 with smoking cessation.","date":"2012","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22373943","citation_count":24,"is_preprint":false},{"pmid":"23727823","id":"PMC_23727823","title":"GALR1 methylation in vaginal swabs is highly accurate in identifying women with endometrial cancer.","date":"2013","source":"International journal of gynecological cancer : official journal of the International Gynecological Cancer Society","url":"https://pubmed.ncbi.nlm.nih.gov/23727823","citation_count":23,"is_preprint":false},{"pmid":"26572146","id":"PMC_26572146","title":"Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.","date":"2015","source":"Clinical & experimental metastasis","url":"https://pubmed.ncbi.nlm.nih.gov/26572146","citation_count":22,"is_preprint":false},{"pmid":"15930442","id":"PMC_15930442","title":"Human galanin (GAL) and galanin 1 receptor (GALR1) variations are not involved in fat intake and early onset obesity.","date":"2005","source":"The Journal of nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/15930442","citation_count":22,"is_preprint":false},{"pmid":"30487761","id":"PMC_30487761","title":"Inhibition of GALR1 in PFC Alleviates Depressive-Like Behaviors in Postpartum Depression Rat Model by Upregulating CREB-BNDF and 5-HT Levels.","date":"2018","source":"Frontiers in psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/30487761","citation_count":20,"is_preprint":false},{"pmid":"15944015","id":"PMC_15944015","title":"Increased hyperalgesia after tissue injury and faster recovery of allodynia after nerve injury in the GalR1 knockout mice.","date":"2005","source":"Neuropeptides","url":"https://pubmed.ncbi.nlm.nih.gov/15944015","citation_count":20,"is_preprint":false},{"pmid":"37422471","id":"PMC_37422471","title":"Alleviation of Limosilactobacillus reuteri in polycystic ovary syndrome protects against circadian dysrhythmia-induced dyslipidemia via capric acid and GALR1 signaling.","date":"2023","source":"NPJ biofilms and microbiomes","url":"https://pubmed.ncbi.nlm.nih.gov/37422471","citation_count":19,"is_preprint":false},{"pmid":"9808667","id":"PMC_9808667","title":"Pharmacological and biochemical characterization of a recombinant human galanin GALR1 receptor: agonist character of chimeric galanin peptides.","date":"1998","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/9808667","citation_count":19,"is_preprint":false},{"pmid":"28203483","id":"PMC_28203483","title":"Galanin Protects from Caspase-8/12-initiated Neuronal Apoptosis in the Ischemic Mouse Brain via GalR1.","date":"2017","source":"Aging and disease","url":"https://pubmed.ncbi.nlm.nih.gov/28203483","citation_count":18,"is_preprint":false},{"pmid":"12915763","id":"PMC_12915763","title":"Direct inhibitory action of galanin on hypothalamic arcuate nucleus neurones expressing galanin receptor Gal-r1 mRNA.","date":"2003","source":"Neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/12915763","citation_count":17,"is_preprint":false},{"pmid":"30551408","id":"PMC_30551408","title":"Galanin/GalR1-3 system: A promising therapeutic target for myocardial ischemia/reperfusion injury.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/30551408","citation_count":16,"is_preprint":false},{"pmid":"9832123","id":"PMC_9832123","title":"Molecular identification and coexpression of galanin and GalR-1 galanin receptor in the human ocular ciliary epithelium: differential modulation of their expression by the activation of alpha2- and beta2-adrenergic receptors in cultured ciliary epithelial cells.","date":"1998","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9832123","citation_count":16,"is_preprint":false},{"pmid":"25449850","id":"PMC_25449850","title":"Central injection of GalR1 agonist M617 facilitates GLUT4 expression in cardiac muscle of type 2 diabetic rats.","date":"2014","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/25449850","citation_count":14,"is_preprint":false},{"pmid":"17143559","id":"PMC_17143559","title":"Galanin enhances corticosterone secretion from dispersed rat adrenocortical cells through the activation of GAL-R1 and GAL-R2 receptors coupled to the adenylate cyclase-dependent signaling cascade.","date":"2007","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17143559","citation_count":14,"is_preprint":false},{"pmid":"18363852","id":"PMC_18363852","title":"Variation in Galr1 expression determines susceptibility to exocitotoxin-induced cell death in mice.","date":"2008","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/18363852","citation_count":13,"is_preprint":false},{"pmid":"14764000","id":"PMC_14764000","title":"Regulation of galanin receptor GalR1 mRNA expression by ovarian steroids in oestrogen receptor alpha-immunoreactive neurones: identification of distinct populations of neurones in the preoptic area.","date":"2004","source":"Journal of neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/14764000","citation_count":13,"is_preprint":false},{"pmid":"18595677","id":"PMC_18595677","title":"Immunohistochemical localization of galanin receptors (GAL-R1, GAL-R2, and GAL-R3) on myenteric neurons from the sheep and dog stomach.","date":"2008","source":"Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft","url":"https://pubmed.ncbi.nlm.nih.gov/18595677","citation_count":13,"is_preprint":false},{"pmid":"36551197","id":"PMC_36551197","title":"Galanin Receptors (GALR1, GALR2, and GALR3) Immunoexpression in Enteric Plexuses of Colorectal Cancer Patients: Correlation with the Clinico-Pathological Parameters.","date":"2022","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/36551197","citation_count":12,"is_preprint":false},{"pmid":"18602374","id":"PMC_18602374","title":"Galanin inhibits calcium channels via Galpha(i)-protein mediated by GalR1 in rat nucleus tractus solitarius.","date":"2008","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/18602374","citation_count":12,"is_preprint":false},{"pmid":"9928161","id":"PMC_9928161","title":"Mutagenesis study on human galanin receptor GalR1 reveals domains involved in ligand binding.","date":"1998","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/9928161","citation_count":11,"is_preprint":false},{"pmid":"34203944","id":"PMC_34203944","title":"Regulatory Influence of Galanin and GALR1/GALR2 Receptors on Inflamed Uterus Contractility in Pigs.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34203944","citation_count":10,"is_preprint":false},{"pmid":"27175780","id":"PMC_27175780","title":"The Influence of Gastric Antral Ulcerations on the Expression of Galanin and GalR1, GalR2, GalR3 Receptors in the Pylorus with Regard to Gastric Intrinsic Innervation of the Pyloric Sphincter.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27175780","citation_count":10,"is_preprint":false},{"pmid":"27041232","id":"PMC_27041232","title":"Central injection of GALR1 agonist M617 attenuates diabetic rat skeletal muscle insulin resistance through the Akt/AS160/GLUT4 pathway.","date":"2016","source":"Mechanisms of ageing and development","url":"https://pubmed.ncbi.nlm.nih.gov/27041232","citation_count":10,"is_preprint":false},{"pmid":"33768673","id":"PMC_33768673","title":"Cell-type specific expression and behavioral impact of galanin and GalR1 in the locus coeruleus during opioid withdrawal.","date":"2021","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/33768673","citation_count":10,"is_preprint":false},{"pmid":"11900829","id":"PMC_11900829","title":"Expression of galanin receptor-1 (GALR1) in the rat trigeminal ganglia and molar teeth.","date":"2002","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/11900829","citation_count":10,"is_preprint":false},{"pmid":"15748163","id":"PMC_15748163","title":"Induction of galanin receptor-1 (GalR1) expression in external granule cell layer of post-natal mouse cerebellum.","date":"2005","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15748163","citation_count":10,"is_preprint":false},{"pmid":"20977910","id":"PMC_20977910","title":"Characterization of the chicken galanin type I receptor (GalR1) and a novel GalR1-like receptor (GalR1-L).","date":"2010","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/20977910","citation_count":8,"is_preprint":false},{"pmid":"34108238","id":"PMC_34108238","title":"Involvement of Scratch2 in GalR1-mediated depression-like behaviors in the rat ventral periaqueductal gray.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34108238","citation_count":6,"is_preprint":false},{"pmid":"23142608","id":"PMC_23142608","title":"Galanin, through GalR1 but not GalR2 receptors, decreases motivation at times of high appetitive behavior.","date":"2012","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/23142608","citation_count":6,"is_preprint":false},{"pmid":"26504828","id":"PMC_26504828","title":"A Pyrosequencing Assay for the Quantitative Methylation Analysis of GALR1 in Endometrial Samples: Preliminary Results.","date":"2015","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/26504828","citation_count":5,"is_preprint":false},{"pmid":"9879063","id":"PMC_9879063","title":"Retrovirus-mediated expression of the GalR1 galanin receptor: implication for efficient stable expression of functional G protein-coupled receptors.","date":"1998","source":"Journal of receptor and signal transduction research","url":"https://pubmed.ncbi.nlm.nih.gov/9879063","citation_count":4,"is_preprint":false},{"pmid":"35606503","id":"PMC_35606503","title":"Promoter hypermethylation of GALR1 acts as an early epigenetic susceptibility event in colorectal carcinogenesis.","date":"2022","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35606503","citation_count":3,"is_preprint":false},{"pmid":"32606704","id":"PMC_32606704","title":"Association Between Polymorphisms in the 5' Region of the GALR1 Gene and Schizophrenia in the Northern Chinese Han Population: A Case-Control Study.","date":"2020","source":"Neuropsychiatric disease and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/32606704","citation_count":3,"is_preprint":false},{"pmid":"38632282","id":"PMC_38632282","title":"Glyphosate-induced changes in the expression of galanin and GALR1, GALR2 and GALR3 receptors in the porcine small intestine wall.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/38632282","citation_count":3,"is_preprint":false},{"pmid":"40024300","id":"PMC_40024300","title":"GALR1 and PENK serve as potential biomarkers in invasive non-functional pituitary neuroendocrine tumours.","date":"2025","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/40024300","citation_count":2,"is_preprint":false},{"pmid":"34370270","id":"PMC_34370270","title":"Time-restricted feeding prevents metabolic diseases through the regulation of galanin/GALR1 expression in the hypothalamus of mice.","date":"2021","source":"Eating and weight disorders : EWD","url":"https://pubmed.ncbi.nlm.nih.gov/34370270","citation_count":1,"is_preprint":false},{"pmid":"41822106","id":"PMC_41822106","title":"Intravenous galanin (1-16) and a GalR1 agonist attenuate allodynia in rats with spared nerve injury.","date":"2026","source":"Pain reports","url":"https://pubmed.ncbi.nlm.nih.gov/41822106","citation_count":0,"is_preprint":false},{"pmid":"40032112","id":"PMC_40032112","title":"The potential neuro-oncology link of GALR1 protein molecular mechanism in breast cancer: Expression in BT549 and MDA-MB-231 cells and its role in proliferation and migration.","date":"2025","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/40032112","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.07.29.605653","title":"Galanin receptor 1 expressing neurons in hippocampal-prefrontal circuitry modulate goal directed attention and impulse control","date":"2024-07-30","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.29.605653","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":39107,"output_tokens":5931,"usd":0.103143},"stage2":{"model":"claude-opus-4-6","input_tokens":9508,"output_tokens":3513,"usd":0.203047},"total_usd":0.30619,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"GalR1 couples to Gi protein to inhibit adenylyl cyclase (cAMP production), and activates MAPK through a Gi-betagamma signaling pathway (sensitive to beta-ARKct inhibition but not PKC inhibition), while failing to couple to Gs or Gq/G11.\",\n      \"method\": \"CHO cell transfection, cAMP assay, pertussis toxin treatment, beta-ARKct expression, PKC inhibitor treatment, MAPK assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal pharmacological and signaling assays in recombinant system, replicated across GalR1 vs GalR2 comparisons\",\n      \"pmids\": [\"9578554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Rat GALR1 is a G protein-coupled receptor that binds galanin with high affinity and inhibits basal and forskolin-stimulated cAMP formation via a pertussis toxin-sensitive G protein in CHO cells.\",\n      \"method\": \"cDNA cloning, radioligand binding in COS1 cells, cAMP assay with pertussis toxin in CHO cells\",\n      \"journal\": \"Brain research. Molecular brain research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted receptor in heterologous cells with functional cAMP assay and pertussis toxin validation\",\n      \"pmids\": [\"8750821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Site-directed mutagenesis of GalR1 identified His264 and Phe282 as directly involved in galanin binding (mutation reduces binding 20-fold but retains partial cAMP signaling), Glu271 interacts with the N-terminus of galanin, and Phe115 in TM III is structurally important for the ligand binding pocket.\",\n      \"method\": \"Site-directed mutagenesis, radioligand binding, adenylyl cyclase inhibition assay\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with mutagenesis and functional assay, multiple residues characterized\",\n      \"pmids\": [\"9370372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The N-terminal portion of galanin binds to a hydrophobic pocket within GalR1, and ligand binding is followed by rapid GalR1-mediated internalization of the agonist-receptor complex via an energy-requiring endocytic process (t1/2 ~10 min, ~78% internalization, blocked by sucrose).\",\n      \"method\": \"Fluorescein-galanin (F-Gal) probe, fluorescence quenching by KI, flow cytometry in transfected CHO cells, temperature and sucrose inhibition controls\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct biophysical measurement of ligand-receptor interaction and receptor internalization with multiple controls\",\n      \"pmids\": [\"9649336\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Molecular modelling and mutagenesis of hGALR1 identified Phe186 in the second extracellular loop as making hydrophobic contact with galanin (Ala7/Leu11); Glu271 interacts with the N-terminus of galanin; Phe115 is structurally important to the binding pocket; and Phe282 interacts with Trp2 of galanin via an aromatic-aromatic interaction.\",\n      \"method\": \"Molecular modelling based on frog rhodopsin alpha-carbon maps, site-directed mutagenesis, radioligand binding with subtype-selective ligands\",\n      \"journal\": \"Protein engineering\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structure-guided mutagenesis with functional binding validation for multiple residues\",\n      \"pmids\": [\"11983932\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Human GALR1 expressed in HEK293E cells shows two affinity states (picomolar and nanomolar), inhibits forskolin-stimulated cAMP, and stimulates GTPgammaS binding; chimeric galanin peptides including M40 act as full agonists at GALR1 in vitro despite antagonist effects in vivo.\",\n      \"method\": \"Stable episomal expression in HEK293E cells, saturation binding isotherms, SPA assay, cAMP inhibition assay, GTPgammaS binding, receptor inactivation by partial alkylation\",\n      \"journal\": \"The Journal of pharmacology and experimental therapeutics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal assays including receptor reserve experiments with rigorous controls\",\n      \"pmids\": [\"9808667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GalR1 activation by the selective agonist M617 inhibits N- and P/Q-type voltage-dependent calcium channels via Galphai-protein betagamma subunits in rat nucleus tractus solitarius neurons.\",\n      \"method\": \"Patch-clamp whole-cell recording, selective GalR1 agonist M617, depolarizing prepulse protocol, intracellular dialysis of Galphai antibody, M35 antagonist\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — electrophysiology with selective agonist/antagonist pharmacology and intracellular antibody blockade of signaling component\",\n      \"pmids\": [\"18602374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GalR1 mediates direct postsynaptic inhibitory actions of galanin on arcuate nucleus neurons by activating an inwardly-rectifying K+ conductance (reversal potential ~-94 mV), confirmed by co-expression of Gal-R1 mRNA in responsive neurons and blockade by galantide.\",\n      \"method\": \"Sharp microelectrode current-clamp recordings in brain slices, biocytin filling, in situ hybridization for Gal-R1 mRNA, TTX treatment, galantide antagonism\",\n      \"journal\": \"Neuroendocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — electrophysiology with pharmacological validation, TTX control, and post-hoc mRNA confirmation in recorded neurons\",\n      \"pmids\": [\"12915763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GalR1 activation in substantia gelatinosa neurons activates an inwardly-rectifying conductance and has little effect on presynaptic spontaneous EPSCs, while GalR2 activation decreases membrane excitability and acts presynaptically to reduce EPSC frequency; consistent with GalR1 coupling to Gi/o.\",\n      \"method\": \"Whole-cell patch-clamp recording in rat spinal cord slices, selective GalR1 agonist cocktail (AR-M961 + M871), selective GalR2 agonist AR-M1896\",\n      \"journal\": \"Pain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — electrophysiology with selective receptor pharmacology distinguishing GalR1 vs GalR2 mechanisms\",\n      \"pmids\": [\"17910903\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GalR1 and its ligand galanin promote chemoresistance in colorectal cancer; silencing GalR1 induces caspase-8-dependent apoptosis by downregulating the caspase-8 inhibitor FLIPL.\",\n      \"method\": \"RNAi functional screening, siRNA knockdown, apoptosis assays, Western blot for caspase-8 and FLIPL\",\n      \"journal\": \"Clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RNAi knockdown with defined molecular pathway (FLIPL/caspase-8), single lab\",\n      \"pmids\": [\"22859720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"GalR1 protein levels in the locus coeruleus are regulated by cAMP-dependent mechanisms: GalR1 (but not GalR2 or GalR3) is upregulated in LC-like Cath.a cells by cAMP elevation and is increased in galanin knockout mice where loss of galanin-maintained cAMP tone leads to increased CREB phosphorylation and elevated GalR1 expression.\",\n      \"method\": \"Western blot, mRNA quantification in cell lines and knockout mice, cAMP manipulation, CREB phosphorylation analysis\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout plus pharmacological cAMP manipulation, single lab\",\n      \"pmids\": [\"15934937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GALR1 knockout mice exhibit spontaneous tonic-clonic seizures and reduced circulating IGF-I levels, demonstrating that GALR1 is required for galanin's anti-seizure activity and for neuroendocrine regulation.\",\n      \"method\": \"Insertional gene knockout, seizure monitoring, IGF-I radioimmunoassay\",\n      \"journal\": \"Brain research. Molecular brain research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean knockout with defined seizure and neuroendocrine phenotype, replicated in second knockout line\",\n      \"pmids\": [\"12487125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GalR1 mediates galanin's protection from seizures and hippocampal injury in Li-pilocarpine and perforant path stimulation models of status epilepticus but not in kainic acid-induced seizures, as shown by more severe seizures and greater CA1 and hilar cell injury in GalR1 knockout mice.\",\n      \"method\": \"GalR1 knockout mice, Li-pilocarpine, electrical PPS, and kainic acid SE models, FluoroJade B, TUNEL staining, BrdU neurogenesis labeling\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean knockout with three independent models and multiple readouts, model-specific dissection of GalR1 role\",\n      \"pmids\": [\"15350653\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Low-dose galanin-induced spinal pronociception is mediated by GalR2 receptors, while high-dose galanin antiallodynic effects in neuropathic pain are mediated by GalR1 receptors, established by comparing equimolar doses of the GalR2-selective agonist AR-M1896 and the GalR1/2 agonist AR-M961 in rat spinal cord.\",\n      \"method\": \"Intrathecal infusion/injection, selective GalR2 agonist AR-M1896, GalR1/2 agonist AR-M961, Bennett neuropathic pain model, von Frey and cold allodynia testing\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — selective agonist pharmacology with dose-response in vivo, receptor subtype dissection\",\n      \"pmids\": [\"11481429\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Spinal antinociception by intrathecal galanin is mediated by GalR1 receptors, and galanin synergizes with morphine and the NMDA antagonist AP-5 at the spinal level, as shown by isobolographic analysis.\",\n      \"method\": \"Intrathecal injection, formalin test with automated flinch detection, isobolographic analysis, comparison of GalR1/2 agonist vs GalR2-selective agonist potencies\",\n      \"journal\": \"The Journal of pharmacology and experimental therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological in vivo study with isobolographic analysis, receptor subtype inferred from agonist pharmacology\",\n      \"pmids\": [\"14610237\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GalR1 and GalR2 form heteroreceptor complexes (GalR1-GalR2 heteromers) in HEK293T cells, demonstrated by proximity ligation assay and BRET2; within the complex, the GalR1 protomer has increased affinity for galanin(1-15) vs galanin(1-29), preferentially inhibiting CREB via Gi, while GalR2 mediates Gq/11-dependent NFAT signaling.\",\n      \"method\": \"Proximity ligation assay, BRET2, CRE luciferase reporter assay, NFAT reporter assay, selective antagonists (M35, M871)\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — heteromer detection with two orthogonal methods plus functional signaling readouts, single lab\",\n      \"pmids\": [\"25152404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GalR1 forms heteroreceptor complexes with 5-HT1A and GPR39, demonstrated by FRET and co-immunopurification; the GalR1-5-HT1A-GPR39 heterocomplex shows different signaling compared to individual homo/monomeric receptors, and this complex formation is modulated by zinc.\",\n      \"method\": \"FRET, co-immunopurification, functional signaling assays, zinc treatment\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — heteromer detection with two methods, functional differences shown, single lab\",\n      \"pmids\": [\"26365466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GalR1 mediates galanin's neuroprotection against ischemic injury by inhibiting caspase-8 and caspase-12-initiated apoptosis (but not caspase-9), potentially via cPKCgamma signaling; GalR2/3 agonist did not replicate the effect and lentiviral GalR1 knockdown abolished galanin-induced neuroprotection.\",\n      \"method\": \"MCAO/reperfusion mouse model, OGD in primary neurons, lentiviral RNAi knockdown of GalR1, GalR2/3 agonist AR-M1896, caspase activity assays, cPKCgamma knockout neurons\",\n      \"journal\": \"Aging and disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — receptor-selective knockdown and knockout neurons with defined apoptotic pathway, single lab\",\n      \"pmids\": [\"28203483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The transcription factor Scratch2 binds to an E-box element in the GalR1 promoter region (-250 to -220) to repress GalR1 gene expression; decreased Scratch2 in the ventral PAG of chronically stressed rats leads to elevated GalR1 expression and depression-like behavior.\",\n      \"method\": \"Promoter reporter assays, Scratch2 binding to E-box (in vitro molecular biology), Scratch2 knockdown in rat vPAG, behavioral testing, RNAscope in situ hybridization\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter functional assay combined with in vivo knockdown and behavioral validation, single lab\",\n      \"pmids\": [\"34108238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"GALR1 mRNA is co-expressed in extrahypothalamic vasopressin/galanin neurons (~95% co-expression) but is absent from cholinergic neurons in the medial septum/diagonal band, suggesting galanin modulates basal forebrain cholinergic activity indirectly rather than via direct GalR1 action on cholinergic neurons.\",\n      \"method\": \"Double in situ hybridization histochemistry with GALR1 and choline acetyltransferase or vasopressin/galanin riboprobes\",\n      \"journal\": \"Brain research. Molecular brain research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — dual-label in situ hybridization with clear cellular resolution, single lab\",\n      \"pmids\": [\"9450684\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Mouse GalR1 coding sequence is uniquely divided into three exons: exon 1 encodes N-terminal region through TM5, exon 2 encodes the third intracellular loop, and exon 3 encodes TM6 through the C-terminus; the receptor functionally inhibits cAMP when expressed from cDNA.\",\n      \"method\": \"Genomic cloning, cDNA cloning, functional cAMP assay in transfected cells\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — genomic structure determined with functional validation, single lab\",\n      \"pmids\": [\"9271210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Under standard autoradiographic binding conditions, [125I]-galanin binding in mouse brain is exclusively attributable to GalR1 (not GalR2 or GalR3), as no specific binding was detected in any brain region of GalR1 knockout mice.\",\n      \"method\": \"Autoradiographic radioligand binding in GalR1 knockout vs wild-type and galanin knockout mouse brain sections\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout confirms receptor identity underlying binding signal, strong evidence\",\n      \"pmids\": [\"15708483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GALR1 knockdown in the prefrontal cortex of postpartum depression model rats alleviates depressive-like behavior and reverses downregulation of CREB-BDNF signaling and 5-HT levels, implicating GalR1 in PFC in suppressing CREB/BDNF/5-HT pathways.\",\n      \"method\": \"siRNA knockdown of GALR1 in rat PFC, behavioral tests, Western blot for CREB-BDNF signaling, HPLC for 5-HT measurement\",\n      \"journal\": \"Frontiers in psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — region-specific knockdown with molecular pathway and behavioral readouts, single lab\",\n      \"pmids\": [\"30487761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GAL-R1 and GAL-R2 (but not GAL-R3) are expressed in rat adrenocortical cells and mediate galanin-stimulated corticosterone secretion via the adenylate cyclase/PKA-dependent signaling pathway (not phospholipase C/PKC), as shown by immunoblockade of receptors and pharmacological inhibitors.\",\n      \"method\": \"RT-PCR, [3H]galanin binding with receptor immunoblockade, cAMP and inositol triphosphate assays, adenylate cyclase and PKA inhibitors, corticosterone RIA\",\n      \"journal\": \"International journal of molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — receptor immunoblockade with pharmacological pathway dissection, multiple readouts\",\n      \"pmids\": [\"17143559\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GalR1 is predominantly expressed in glutamatergic neurons in both the ventral PFC and ventral hippocampus; optogenetic excitation of GalR1-expressing neurons in the vPFC (but not vHC) disrupts visuospatial attention; vPFC GalR1 neurons increase activity during correct attentive actions while vHC GalR1 neurons increase activity during impulsive errors.\",\n      \"method\": \"Multiplex fluorescent in situ hybridization, novel viral approach for GalR1-expressing neuron targeting, optogenetics, fiber photometry, 5-choice serial reaction time task\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — optogenetics and photometry with circuit-specific functional dissection, preprint\",\n      \"pmids\": [\"bio_10.1101_2024.07.29.605653\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"GALR1 is a Gi-coupled GPCR that inhibits adenylyl cyclase, activates MAPK via Gi-betagamma subunits, and inhibits N- and P/Q-type calcium channels; ligand binding involves a hydrophobic pocket with key residues His264, Phe282, Glu271, and Phe115, followed by rapid receptor-mediated internalization; GalR1 can form heteroreceptor complexes with GalR2 (altering galanin fragment selectivity) and with 5-HT1A/GPR39; in vivo, GalR1 mediates galanin's anticonvulsant, antinociceptive, and neuroprotective effects, suppresses pro-apoptotic caspase-8/12 signaling, and modulates cognitive and affective behaviors through glutamatergic neurons in frontotemporal circuits, with its expression regulated by the transcription factor Scratch2 and by cAMP/CREB-dependent mechanisms.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GALR1 is a Gi/o-coupled galanin receptor that functions as an inhibitory modulator of neuronal excitability, nociception, seizure susceptibility, and affective behavior. Upon galanin binding to a hydrophobic pocket involving His264, Phe282, Glu271, Phe115, and Phe186, GALR1 inhibits adenylyl cyclase, activates MAPK via Gβγ subunits, opens inwardly rectifying K⁺ channels, and inhibits N- and P/Q-type voltage-dependent calcium channels, followed by rapid clathrin-dependent receptor internalization [PMID:9578554, PMID:9370372, PMID:9649336, PMID:18602374, PMID:12915763]. GALR1 knockout mice exhibit spontaneous seizures and enhanced hippocampal injury in status epilepticus models, establishing GALR1 as the primary mediator of galanin's anticonvulsant and neuroprotective actions, and high-dose spinal galanin antinociception also operates through GALR1 [PMID:12487125, PMID:15350653, PMID:11481429]. GALR1 forms heteroreceptor complexes with GalR2 and with 5-HT1A/GPR39 that alter ligand selectivity and downstream signaling, and its transcription is repressed by the E-box-binding factor Scratch2 and positively regulated by cAMP/CREB-dependent mechanisms [PMID:25152404, PMID:26365466, PMID:34108238, PMID:15934937].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Cloning of rat GALR1 established it as a high-affinity galanin receptor coupled to pertussis-toxin-sensitive Gi protein that inhibits cAMP, resolving the molecular identity of the first galanin receptor subtype.\",\n      \"evidence\": \"cDNA cloning, radioligand binding in COS1 cells, cAMP assay with pertussis toxin in CHO cells\",\n      \"pmids\": [\"8750821\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream effectors beyond cAMP not yet characterized\", \"In vivo relevance not tested\", \"Receptor subtype selectivity unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Site-directed mutagenesis and genomic characterization defined the ligand-binding pocket architecture of GALR1, identifying His264, Phe282, Glu271, and Phe115 as key determinants of galanin recognition and revealing a unique three-exon gene structure.\",\n      \"evidence\": \"Site-directed mutagenesis with radioligand binding and adenylyl cyclase assays; genomic cloning of mouse GalR1\",\n      \"pmids\": [\"9370372\", \"9271210\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal or cryo-EM structure available\", \"Contributions of extracellular loop residues not yet mapped\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Characterization of GALR1 signaling revealed that it activates MAPK through Gβγ subunits (not PKC), displays two-affinity-state binding, and undergoes rapid agonist-induced internalization, establishing the full proximal signaling and trafficking repertoire.\",\n      \"evidence\": \"CHO and HEK293E cell transfection with βARKct blockade, MAPK assay, fluorescein-galanin internalization by flow cytometry, receptor alkylation studies\",\n      \"pmids\": [\"9578554\", \"9808667\", \"9649336\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Internalization machinery (arrestin involvement) not identified\", \"Recycling versus degradation fate unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Selective agonist pharmacology in vivo demonstrated that spinal antinociception at high galanin doses is specifically mediated by GALR1, separating it from GalR2-mediated pronociceptive effects and establishing GALR1 as a therapeutic target for neuropathic pain.\",\n      \"evidence\": \"Intrathecal GalR1/2 agonist AR-M961 vs GalR2-selective AR-M1896 in rat Bennett neuropathic pain model with allodynia testing\",\n      \"pmids\": [\"11481429\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Spinal circuit identity of GalR1-expressing neurons unknown\", \"Whether GALR1 is sufficient or only necessary for antiallodynia not resolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"GALR1 knockout mice showed spontaneous seizures and reduced IGF-I, proving GALR1 is required for galanin's anticonvulsant function and contributes to neuroendocrine homeostasis — the first genetic loss-of-function evidence for a galanin receptor in vivo.\",\n      \"evidence\": \"Insertional gene knockout, seizure monitoring, IGF-I radioimmunoassay; further refined by Phe186 mutagenesis of the binding pocket\",\n      \"pmids\": [\"12487125\", \"11983932\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Seizure mechanism (circuit vs molecular) not dissected\", \"Compensatory changes in GalR2/R3 not assessed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Electrophysiology in brain slices revealed that GALR1 mediates postsynaptic inhibition by activating inwardly rectifying K⁺ channels in arcuate nucleus neurons, defining the ionic mechanism underlying GALR1's inhibitory actions on neuronal excitability.\",\n      \"evidence\": \"Sharp microelectrode recordings in brain slices with galantide antagonism, TTX, and post-hoc in situ hybridization for GalR1 mRNA\",\n      \"pmids\": [\"12915763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific GIRK channel subunit identity not determined\", \"Whether this mechanism generalizes to all GALR1-expressing neurons unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Model-specific analysis in GALR1 knockouts demonstrated that GALR1's neuroprotective role extends to hippocampal cell survival during status epilepticus (pilocarpine and perforant path models) but not kainic acid seizures, revealing stimulus-dependent engagement of the receptor.\",\n      \"evidence\": \"GalR1 knockout mice in three SE models, FluoroJade B and TUNEL staining, BrdU neurogenesis labeling\",\n      \"pmids\": [\"15350653\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why kainic acid seizures bypass GALR1 is unexplained\", \"Downstream neuroprotective effectors not identified at this stage\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"GALR1 expression itself is regulated by cAMP/CREB signaling — a feedback loop whereby Gi-mediated cAMP suppression by galanin normally restrains GALR1 levels, while loss of galanin tone increases CREB phosphorylation and upregulates GALR1.\",\n      \"evidence\": \"Western blot and mRNA quantification in Cath.a cells and galanin knockout mice with cAMP manipulation and CREB phosphorylation analysis\",\n      \"pmids\": [\"15934937\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether CREB directly binds the GALR1 promoter not shown\", \"Feedback dynamics under physiological conditions not measured\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"GALR1 was shown to inhibit N- and P/Q-type calcium channels via Gαi-βγ subunits and to act purely postsynaptically in spinal cord, further distinguishing its effector repertoire from GalR2's presynaptic actions.\",\n      \"evidence\": \"Patch-clamp in NTS neurons with selective agonist M617, Gαi antibody dialysis; whole-cell recordings in spinal substantia gelatinosa slices with receptor-selective agonists\",\n      \"pmids\": [\"18602374\", \"17910903\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Calcium channel subunit specificity (α1 subunit identity) not determined\", \"Mechanism of voltage-dependent relief not fully resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Discovery that GALR1 forms heteroreceptor complexes with GalR2 (shifting galanin fragment selectivity and Gi vs Gq coupling bias) and promotes chemoresistance in colorectal cancer by suppressing caspase-8/FLIPL-dependent apoptosis expanded GALR1's roles beyond classical neuromodulation.\",\n      \"evidence\": \"PLA and BRET2 for heteromer detection with CRE/NFAT reporters; RNAi screening in CRC cells with caspase-8 and FLIPL Western blots\",\n      \"pmids\": [\"25152404\", \"22859720\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GalR1-GalR2 heteromer existence in native neurons not confirmed\", \"FLIPL regulation mechanism (transcriptional vs post-translational) not resolved\", \"Cancer relevance based on cell lines only\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"GALR1 was identified as the specific receptor subtype mediating galanin's neuroprotection against ischemic injury, acting through inhibition of caspase-8 and caspase-12 (but not caspase-9), potentially via cPKCγ signaling.\",\n      \"evidence\": \"MCAO/reperfusion model, OGD in primary neurons, lentiviral GalR1 knockdown, cPKCγ knockout neurons, caspase activity assays\",\n      \"pmids\": [\"28203483\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"cPKCγ link is correlative, not yet confirmed by rescue experiments\", \"Whether caspase-8 inhibition in ischemia and cancer share the same mechanism unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Region-specific GALR1 knockdown in prefrontal cortex alleviated depression-like behavior and restored CREB-BDNF-5-HT signaling, directly linking cortical GALR1 activity to suppression of monoaminergic and neurotrophic pathways relevant to mood.\",\n      \"evidence\": \"siRNA knockdown of GALR1 in rat PFC, behavioral tests, Western blot, HPLC for 5-HT\",\n      \"pmids\": [\"30487761\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cell-type specificity of PFC GALR1 effects not determined\", \"Whether CREB-BDNF suppression is direct or secondary to cAMP inhibition unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of Scratch2 as a transcriptional repressor of GALR1 via an E-box element in the promoter provided the first defined transcription factor regulating GALR1 expression and linked this regulation to stress-induced depression-like behavior.\",\n      \"evidence\": \"Promoter reporter assays, Scratch2 knockdown in rat ventral PAG, RNAscope in situ hybridization, behavioral testing\",\n      \"pmids\": [\"34108238\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct Scratch2 binding to GALR1 promoter not shown by ChIP\", \"Whether Scratch2 regulation is brain-region specific not addressed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of GALR1 activation (no experimental structure), the identity of arrestin/scaffolding proteins mediating internalization, whether GalR1-GalR2 and GalR1-5HT1A heteromers exist in native brain tissue, and the cell-type-specific circuit mechanisms by which GALR1 controls seizure threshold and affective behavior.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No experimental 3D structure of GALR1\", \"Heteromer formation unconfirmed in vivo\", \"Circuit-level mechanism of anticonvulsant action not resolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1, 5, 6, 7, 8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [6, 7, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 5, 15]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 5, 6, 7, 8, 15, 16]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [6, 7, 8, 12, 13]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [9, 17]}\n    ],\n    \"complexes\": [\n      \"GalR1-GalR2 heteromer\",\n      \"GalR1-5-HT1A-GPR39 heterocomplex\"\n    ],\n    \"partners\": [\n      \"GALR2\",\n      \"HTR1A\",\n      \"GPR39\",\n      \"GAL\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}